Cargando…

Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity

Exchange proteins directly activated by cAMP (Epac) proteins are implicated in a wide range of cellular functions including oxidative stress and cell survival. Mitochondrial-dependent oxidative stress has been associated with progressive neuronal death underlying the pathology of many neurodegenerat...

Descripción completa

Detalles Bibliográficos
Autores principales: Musheshe, Nshunge, Oun, Asmaa, Sabogal-Guáqueta, Angélica María, Trombetta-Lima, Marina, Mitchel, Sarah C., Adzemovic, Ahmed, Speek, Oliver, Morra, Francesca, van der Veen, Christina H. J. T., Lezoualc’h, Frank, Cheng, Xiaodong, Schmidt, Martina, Dolga, Amalia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868285/
https://www.ncbi.nlm.nih.gov/pubmed/35204198
http://dx.doi.org/10.3390/antiox11020314
_version_ 1784656231313440768
author Musheshe, Nshunge
Oun, Asmaa
Sabogal-Guáqueta, Angélica María
Trombetta-Lima, Marina
Mitchel, Sarah C.
Adzemovic, Ahmed
Speek, Oliver
Morra, Francesca
van der Veen, Christina H. J. T.
Lezoualc’h, Frank
Cheng, Xiaodong
Schmidt, Martina
Dolga, Amalia M.
author_facet Musheshe, Nshunge
Oun, Asmaa
Sabogal-Guáqueta, Angélica María
Trombetta-Lima, Marina
Mitchel, Sarah C.
Adzemovic, Ahmed
Speek, Oliver
Morra, Francesca
van der Veen, Christina H. J. T.
Lezoualc’h, Frank
Cheng, Xiaodong
Schmidt, Martina
Dolga, Amalia M.
author_sort Musheshe, Nshunge
collection PubMed
description Exchange proteins directly activated by cAMP (Epac) proteins are implicated in a wide range of cellular functions including oxidative stress and cell survival. Mitochondrial-dependent oxidative stress has been associated with progressive neuronal death underlying the pathology of many neurodegenerative diseases. The role of Epac modulation in neuronal cells in relation to cell survival and death, as well as its potential effect on mitochondrial function, is not well established. In immortalized hippocampal (HT-22) neuronal cells, we examined mitochondria function in the presence of various Epac pharmacological modulators in response to oxidative stress due to ferroptosis. Our study revealed that selective pharmacological modulation of Epac1 or Epac2 isoforms, exerted differential effects in erastin-induced ferroptosis conditions in HT-22 cells. Epac1 inhibition prevented cell death and loss of mitochondrial integrity induced by ferroptosis, while Epac2 inhibition had limited effects. Our data suggest Epac1 as a plausible therapeutic target for preventing ferroptosis cell death associated with neurodegenerative diseases.
format Online
Article
Text
id pubmed-8868285
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88682852022-02-25 Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity Musheshe, Nshunge Oun, Asmaa Sabogal-Guáqueta, Angélica María Trombetta-Lima, Marina Mitchel, Sarah C. Adzemovic, Ahmed Speek, Oliver Morra, Francesca van der Veen, Christina H. J. T. Lezoualc’h, Frank Cheng, Xiaodong Schmidt, Martina Dolga, Amalia M. Antioxidants (Basel) Article Exchange proteins directly activated by cAMP (Epac) proteins are implicated in a wide range of cellular functions including oxidative stress and cell survival. Mitochondrial-dependent oxidative stress has been associated with progressive neuronal death underlying the pathology of many neurodegenerative diseases. The role of Epac modulation in neuronal cells in relation to cell survival and death, as well as its potential effect on mitochondrial function, is not well established. In immortalized hippocampal (HT-22) neuronal cells, we examined mitochondria function in the presence of various Epac pharmacological modulators in response to oxidative stress due to ferroptosis. Our study revealed that selective pharmacological modulation of Epac1 or Epac2 isoforms, exerted differential effects in erastin-induced ferroptosis conditions in HT-22 cells. Epac1 inhibition prevented cell death and loss of mitochondrial integrity induced by ferroptosis, while Epac2 inhibition had limited effects. Our data suggest Epac1 as a plausible therapeutic target for preventing ferroptosis cell death associated with neurodegenerative diseases. MDPI 2022-02-04 /pmc/articles/PMC8868285/ /pubmed/35204198 http://dx.doi.org/10.3390/antiox11020314 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Musheshe, Nshunge
Oun, Asmaa
Sabogal-Guáqueta, Angélica María
Trombetta-Lima, Marina
Mitchel, Sarah C.
Adzemovic, Ahmed
Speek, Oliver
Morra, Francesca
van der Veen, Christina H. J. T.
Lezoualc’h, Frank
Cheng, Xiaodong
Schmidt, Martina
Dolga, Amalia M.
Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity
title Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity
title_full Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity
title_fullStr Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity
title_full_unstemmed Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity
title_short Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity
title_sort pharmacological inhibition of epac1 averts ferroptosis cell death by preserving mitochondrial integrity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868285/
https://www.ncbi.nlm.nih.gov/pubmed/35204198
http://dx.doi.org/10.3390/antiox11020314
work_keys_str_mv AT musheshenshunge pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity
AT ounasmaa pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity
AT sabogalguaquetaangelicamaria pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity
AT trombettalimamarina pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity
AT mitchelsarahc pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity
AT adzemovicahmed pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity
AT speekoliver pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity
AT morrafrancesca pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity
AT vanderveenchristinahjt pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity
AT lezoualchfrank pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity
AT chengxiaodong pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity
AT schmidtmartina pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity
AT dolgaamaliam pharmacologicalinhibitionofepac1avertsferroptosiscelldeathbypreservingmitochondrialintegrity